Publication | Closed Access

Impact Analysis of Autoantibody Level and NR2 Antibody Level in Neuropsychiatric SLE Treated by Methylprednisolone Combined with MTX and DXM Intrathecal Injection

Impact AnalysisMethylprednisolone CombinedAutoimmune DiseasePsychiatryNr2 Antibody LevelMedicinePsychotropic MedicationClinical NeurologyNeuropharmacologyNeuropsychiatryPharmacotherapyNeuroscienceBiological PsychiatryMultiple SclerosisNeurologyNeuroimmunology